Work

P3.12E.02 MEK Inhibitor Combined with RTK Inhibitor (Trametinib Plus Anlotinib) In Non-g12c KRAS-Mutant Non-Small Cell Lung Cancer: A New Strategy

Year: 2024

Type: article

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2024.09.634

Authors: B. Han, J. Lu, H. Zhong, T. Chu, W. Zhang, M. Hu, C. Shi, L. Xiong, A. Gu, H. Wang

Institutions: Shanghai Jiao Tong University, Shanghai Chest Hospital

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4403410123

FWCI: 0.289

Cites:

Cited by: 1

Related to: 10